ClinicalTrials.Veeva

Menu

Comparison Between LDCT With DL Recontruction and Standard Dose CT

Seoul National University logo

Seoul National University

Status

Active, not recruiting

Conditions

Liver Metastases

Treatments

Diagnostic Test: contrast-enhanced abdomen CT

Study type

Observational

Funder types

Other

Identifiers

NCT05324046
2022-0410

Details and patient eligibility

About

This prospective study aims to perform intra-individual comparison of the image quality between low dose liver CT with deep learning reconstruction and standard dose liver CT with iterative reconstruction in patients with liver metastasis.

Enrollment

134 patients

Sex

All

Ages

20 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with underlying malignancy and suspicion of liver metastasis
  • patients with known liver metastasis and on follow-up
  • AND scheduled for contrast enhanced abdomen CT
  • signed informed consent

Exclusion criteria

  • absolute or relative contra-indication for contrast-enhanced CT
  • diffuse infiltrative liver lesion or multiple (> 10) metastases

Trial design

134 participants in 1 patient group

Liver metastasis
Description:
Patients with suspicion of liver metastasis and scheduled for CT
Treatment:
Diagnostic Test: contrast-enhanced abdomen CT

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems